Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Medtronic
McKinsey
AstraZeneca
McKesson

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

AMMONIA N 13 Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Ammonia N 13 patents expire, and when can generic versions of Ammonia N 13 launch?

Ammonia N 13 is a drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens Hosp, Cardinal Health 414, Central Radiopharm, Decatur, Essential Isotopes, Feinstein, Gen Hosp, Houston Cyclotron, Ionetix, Johns Hopkins Univ, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Spectron Mrc Llc, Ucla Biomedical, Ucsf Rodiopharm, Univ Tx Md Anderson, Wa Univ Sch Med, and Wi Medcl Cyclotron. and is included in twenty-seven NDAs.

The generic ingredient in AMMONIA N 13 is ammonia n-13. There are two drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ammonia n-13 profile page.

Summary for AMMONIA N 13
Drug patent expirations by year for AMMONIA N 13
Recent Clinical Trials for AMMONIA N 13

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
MallinckrodtPhase 3
Rubius TherapeuticsPhase 1
Zagazig UniversityN/A

See all AMMONIA N 13 clinical trials

Pharmacology for AMMONIA N 13
Synonyms for AMMONIA N 13
((sup 13)N)Ammonia
(13n)ammonia
[13N]Ammonia
[13N]NH3
34819-78-8
9OQO0E343Z
AC1L3OST
Ammonia (13N)
Ammonia N 13 (TN)
Ammonia N 13 (USP)
Ammonia N 13 [USAN:USP]
Ammonia N 13 Injection
AMMONIA N-13
Ammonia N13
Ammonia-(sup 13)N
CHEBI:135980
CHEMBL1201189
D02915
DB09326
MOLI001000
MOLI001060
N-13 Ammonia
Nitrogen, isotope of mass 13, at.
QGZKDVFQNNGYKY-BJUDXGSMSA-N
UNII-9OQO0E343Z

US Patents and Regulatory Information for AMMONIA N 13

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3d Imaging Drug AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 203779-001 Oct 19, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Petnet AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204510-001 Nov 2, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Ucsf Rodiopharm AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204496-001 Mar 28, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Essential Isotopes AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 205687-001 Dec 17, 2015 RX No No   Start Trial   Start Trial   Start Trial
Cardinal Health 414 AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 203700-001 Feb 25, 2013 AP RX No No   Start Trial   Start Trial   Start Trial
Johns Hopkins Univ AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204514-001 Aug 19, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Shertech Labs Llc AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204366-001 Sep 19, 2014 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Moodys
McKesson
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.